Weiner I, Shadach E, Barkai R, Feldon J
Department of Psychology, Tel-Aviv University, Ramat-Aviv, Israel.
Neuropsychopharmacology. 1997 Jan;16(1):42-50. doi: 10.1016/S0893-133X(96)00145-5.
Latent inhibition (LI) refers to retarded conditioning to a stimulus as a consequence of its nonreinforced preexposure. LI is impaired in acute schizophrenic patients and in rats treated with amphetamine. Neuroleptic drugs enhance LI, and this effect is selective and specific for this class of drugs. The present experiments tested the proposition that neuroleptic-induced enhancement of LI stems from decreased capacity of stimulus-preexposed animals to switch responding according to the new stimulus-reinforcement contingency in the conditioning stage. LI was assessed using an off-baseline conditioned emotional response (CER) procedure in rats licking for water, consisting of three stages: preexposure to the-to-be conditioned stimulus, tone; conditioning, in which the preexposed stimulus was paired with a foot-shock; and test, in which LI was indexed by animals' degree of suppression of licking during tone presentation. Whereas in previous studies that demonstrated LI enhancement by neuroleptics, preexposure consisted of 10 to 40 tones, and conditioning included two tone-shock pairings, the present experiments used 40 tone preexposures, followed by an extended conditioning stage with five tone-shock pairings. It was expected that under these conditions no LI effect would be evident in untreated animals, but that animals treated with a neuroleptic drug, either during the entire LI procedure or only in conditioning, would show LI. Experiments 1 and 2 showed that LI was obtained in rats treated with haloperidol (0.1 mg/kg in experiment 1, 0.03 and 0.2 mg/kg in experiment 2) but not in the untreated controls. Experiment 3 showed that the same outcome was obtained when haloperidol (0.1 mg/kg) administration was confined to the conditioning stage. Experiment 4 showed that clozapine (5 mg/kg)-treated animals showed LI when the drug was confined to conditioning, but not to the preexposure stage. The implications of these results for the mechanism of action of neuroleptic drugs are discussed.
潜伏抑制(LI)是指由于刺激在无强化条件下的预先暴露,导致对该刺激的条件反射形成延迟。急性精神分裂症患者以及用苯丙胺处理过的大鼠的潜伏抑制均受损。抗精神病药物可增强潜伏抑制,且这种效应具有选择性和特异性,仅针对这类药物。本实验检验了这样一个观点,即抗精神病药物诱导的潜伏抑制增强源于预先暴露于刺激的动物在条件反射阶段根据新的刺激 - 强化偶联改变反应的能力下降。使用一种基于基线的条件性情绪反应(CER)程序来评估大鼠舔水行为中的潜伏抑制,该程序包括三个阶段:对即将成为条件刺激的音调进行预先暴露;条件反射阶段,在此阶段将预先暴露的刺激与足部电击配对;测试阶段,通过动物在音调呈现期间舔水抑制程度来衡量潜伏抑制。在先前证明抗精神病药物增强潜伏抑制的研究中,预先暴露包括10至40次音调呈现,条件反射包括两次音调 - 电击配对,而本实验使用40次音调预先暴露,并随后进行包含五次音调 - 电击配对的延长条件反射阶段。预计在这些条件下,未处理的动物不会出现明显的潜伏抑制效应,但在整个潜伏抑制程序期间或仅在条件反射阶段用抗精神病药物处理的动物会表现出潜伏抑制。实验1和实验2表明,用氟哌啶醇处理的大鼠(实验1中为0.1mg/kg,实验2中为0.03mg/kg和)表现出潜伏抑制,而未处理的对照组则没有。实验3表明,当氟哌啶醇(0.1mg/kg)给药仅限于条件反射阶段时,也得到了相同的结果。实验4表明,当氯氮平(5mg/kg)给药仅限于条件反射阶段而非预先暴露阶段时,处理过的动物表现出潜伏抑制。讨论了这些结果对抗精神病药物作用机制的意义。